Testing effectiveness (Phase 2)Study completedNCT03013543
What this trial is testing
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
Who this might be right for
Genetic ObesityObesityObesity Due to Melanocortin 4 Receptor Deficiency
Rhythm Pharmaceuticals, Inc. 213